DOI: 10.1055/s-00035024

Thrombosis and Haemostasis


Prins MH, Lensing AWA, Brighton TA. , et al.
Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials.

Lancet Haematol 2014;
1 (01) e37-e46

Download Bibliographical Data